[ad_1]
(MedPage Today) — Two neoadjuvant immunotherapy combinations for head and neck cancer substantially increased the response rate versus a single drug, a small randomized trial showed.
The pathologic tumor response (pTR) rate increased from 41…
[ad_2]
Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/114724
Author :
Publish date : 2025-03-18 21:35:00
Copyright for syndicated content belongs to the linked Source.
Better Response, Survival in Head and Neck Cancer With Dual Pre-Op Immunotherapy
Related Posts
